Grant supports efforts to utilize rHEALTH’s point-of-care technology for monitoring FVIII and emicizumab levels in hemophilia A patients
BEDFORD, Mass., October 8, 2020 – rHEALTH LLC, a Diagnose Yourself, AnywhereTM company, today announced that its technology is the subject of the award from the National Institute of Health (NIH). The award is to rHEALTH’s affiliate,...
Read more
rHEALTH Technology Granted US Patent for Small Volume Blood Handling in Point-of-Care Devices
Invention enables manipulation of small blood samples for accurate point-of-care diagnosis
BEDFORD, Mass., January 5, 2020 – rHEALTH LLC, and its affiliate DNA Medicine Institute, Inc., announced today the issuance of United States Patent Number 10,449,537 titled “Capillary manipulation of clinical samples.” The patent describes a system for collection and delivery of minute blood samples to...
Read more
rHEALTH ONE Blood Analyzers Delivered to NASA for International Space Station
Blood analyzers to be qualified for spaceflight by NASA’s Commercial-Off-The Shelf (COTS) certification process
CAMBRIDGE, Mass., September 30, 2019 – rHEALTH LLC, and its affiliate DNA Medicine Institute, Inc., today announced that rHEALTH ONE blood analyzers have been delivered to NASA and its prime contractor Zin Technologies for spaceflight qualification. The technology will undergo a rigorous...
Read more
Abstracts for rHEALTH’s Factor VIII and Platelet Tests Accepted for Poster and Oral Presentations at Upcoming AACC 2019 Meeting
rHEALTH tests to be presented at the industry’s leading annual conference for laboratory medicine
CAMBRIDGE, Mass., July 11, 2019 – rHEALTH LLC, and its affiliate DNA Medicine Institute, Inc., today announced that both of its abstracts have been accepted via peer-review from for the 2019 American Association of Clinical Chemistry (AACC) meeting. The titles and details...
Read more
rHEALTH Nanostrips, Vitals Device, and Fluidics Module to Receive U.S. Patent Protection
rHEALTH Nanostrips, Vitals Device, and Fluidics Module to Receive U.S. Patent Protection. Expands patent protection for diagnose yourself, anywhere technology
CAMBRIDGE, Mass., May 21, 2019 -- DNA Medicine Institute, Inc., and its affiliate rHEALTH LLC, today announced that three separate aspects of its technology platform has received a Notice of Allowance and two Issue Notifications from the...
Read more